Physician profile
Dennis Katechis
NPI 1033129978
$10,724.74
in general payments reported to CMS, 2019-2025
43 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,008 · 2020: $604 · 2021: $789 · 2022: $953 · 2023: $1,911 · 2024: $2,773 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,272 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,271.50 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,059.06 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $1,487.94 | 2019-2025 | |
| Amgen INC. | $1,124.33 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $642.57 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $529.94 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Janssen Pharmaceuticals, INC | $520.63 | 2019-2024 | Xarelto |
| Abiomed | $511.72 | 2024 | Impella |
| Pfizer INC. | $454.46 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $354.11 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $315.89 | 2019-2024 | Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.41 | 2019-2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $225.90 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $187.06 | 2021-2025 | Nexletol |
| Medtronic, INC. | $170.12 | 2024 | Corevalve Evolut R |
| Baxter Healthcare | $157.59 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Katechis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.